BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 35 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,999 | -54.3% | 75,753 | -0.2% | 0.00% | – |
| Q4 2022 | $54,646 | -40.6% | 75,898 | -0.2% | 0.00% | – |
| Q3 2022 | $92,000 | +1.1% | 76,083 | -0.4% | 0.00% | – |
| Q2 2022 | $91,000 | -44.2% | 76,370 | +1.1% | 0.00% | – |
| Q1 2022 | $163,000 | +44.2% | 75,522 | +0.2% | 0.00% | – |
| Q4 2021 | $113,000 | -48.4% | 75,387 | +0.4% | 0.00% | – |
| Q3 2021 | $219,000 | -11.3% | 75,088 | +0.4% | 0.00% | – |
| Q2 2021 | $247,000 | -37.8% | 74,769 | -29.2% | 0.00% | – |
| Q1 2021 | $397,000 | +8.5% | 105,623 | +2.1% | 0.00% | – |
| Q4 2020 | $366,000 | -45.7% | 103,450 | +0.9% | 0.00% | – |
| Q3 2020 | $674,000 | -12.7% | 102,563 | -1.1% | 0.00% | – |
| Q2 2020 | $772,000 | +62.9% | 103,744 | +2.9% | 0.00% | – |
| Q1 2020 | $474,000 | – | 100,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 159,500 | $563,000 | 0.11% |
| Ikarian Capital, LLC | 500,000 | $1,765,000 | 0.08% |
| Anson Funds Management LP | 99,103 | $350,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 66,558 | $235,000 | 0.04% |
| AJU IB Investment Co., Ltd. | 25,651 | $91,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $187,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 12,941 | $46,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $879,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $21,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |